Titan Medical has entered into a non-binding memorandum of understanding (MOU) with Switzerland-based Clinique Generale-Beaulieu (CGB).
As per the understanding, CGB will conduct test and assess Titan’s Amadeus next generation robotic surgical technologies.
After conducting tests, CGB will provide detailed feedback to Titan Medical.
Titan Medical president Reiza Rayman said securing a relationship with CGB further supports the company’s development and future commercialization efforts internationally.
"This relationship is expected to provide future additional opportunities for us to expand our presence in countries where interest in robotic surgery is rapidly growing," Rayman added.